Commentary on "the risky business of studying prognosis"

Anna Broder; Chaim Putterman

doi:10.3899/jrheum.130393

Commentary on "the risky business of studying prognosis"

Anna Broder, Chaim Putterman

Medicine

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1771
Number of pages	1
Journal	Journal of Rheumatology
Volume	40
Issue number	10
DOIs	https://doi.org/10.3899/jrheum.130393
State	Published - Oct 2013

ASJC Scopus subject areas

Rheumatology
Immunology and Allergy
Immunology

Access to Document

10.3899/jrheum.130393

Cite this

@article{e89f9019cf014fff81de1d33379db9c3,

title = "Commentary on {"}the risky business of studying prognosis{"}",

author = "Anna Broder and Chaim Putterman",

year = "2013",

month = oct,

doi = "10.3899/jrheum.130393",

language = "English (US)",

volume = "40",

pages = "1771",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "10",

}

TY - JOUR

T1 - Commentary on "the risky business of studying prognosis"

AU - Broder, Anna

AU - Putterman, Chaim

PY - 2013/10

Y1 - 2013/10

UR - http://www.scopus.com/inward/record.url?scp=84885108175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885108175&partnerID=8YFLogxK

U2 - 10.3899/jrheum.130393

DO - 10.3899/jrheum.130393

M3 - Letter

C2 - 24085758

AN - SCOPUS:84885108175

SN - 0315-162X

VL - 40

SP - 1771

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 10

ER -

Commentary on "the risky business of studying prognosis"

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this